Tetragon Partners GP Ltd
An institutional investment manager in GRAND CAYMAN. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 13, 2026. SEC CIK 1515070.
- Reported value$635.1m
- Positions39
Holdings: 39 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31. The filing's table has 43 lines; lines for the same security and option type are added together here.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Uipath IncPATH | CL A | 90364P105 | 336 | 53.0% | 30,950,000 | Added+5,742,372 | |
| Kolibri Global Energy IncKGEI | COM NEW | 50043K406 | 33.8 | 5.3% | 6,834,504 | Unchanged | |
| Autolus Therapeutics LtdAUTL | SPON ADS | 05280R100 | 15.2 | 2.4% | 9,500,000 | Unchanged | |
| Lyft IncLYFT | CL A COM | 55087P104 | 14.6 | 2.3% | 1,000,000 | Unchanged | |
| Definium Therapeutics IncDFTX | COM SHS | 24477V105 | 13.5 | 2.1% | 286,990 | Added+86,996 | |
| Workiva IncWK | COM CL A | 98139A105 | 12.1 | 1.9% | 250,000 | Unchanged | |
| Sprinklr IncCXM | CL A | 85208T107 | 11.4 | 1.8% | 2,200,000 | Unchanged | |
| MBX Biosciences IncMBX | COM | 55287L101 | 11.2 | 1.8% | 203,543 | Added+58,063 | |
| Alkami Technology IncALKT | COM | 01644J108 | 10.9 | 1.7% | 600,284 | New+600,284 | |
| Celldex Therapeutics Inc NewCLDX | COM NEW | 15117B202 | 10.8 | 1.7% | 290,441 | Reduced−21,875 | |
| Relay Therapeutics IncRLAY | COM | 75943R102 | 10.7 | 1.7% | 570,311 | Added+388,768 | |
| Arrowhead Pharmaceuticals inARWR | COM | 04280A100 | 10.6 | 1.7% | 130,484 | Added+3,286 | |
| Pharvaris N V | COM | N69605108 | 10.2 | 1.6% | 295,627 | Added+74,016 | |
| Alkermes plc | SHS | G01767105 | 10.0 | 1.6% | 189,979 | Added+30,188 | |
| Immunovant IncIMVT | COM | 45258J102 | 9.9 | 1.6% | 255,934 | Added+37,427 | |
| Axsome Therapeutics Inc.AXSM | COM | 05464T104 | 8.6 | 1.3% | 35,000 | Call | Unchanged |
| Silence Therapeutics plcSLN | ADS | 82686Q101 | 8.4 | 1.3% | 764,256 | Added+134,095 | |
| Dyne Therapeutics IncDYN | COM | 26818M108 | 7.9 | 1.2% | 356,657 | Added+98,525 | |
| Ionis Pharmaceuticals IncIONS | COM | 462222100 | 7.7 | 1.2% | 97,173 | Added+55,409 | |
| Agios Pharmaceuticals IncAGIO | COM | 00847X104 | 7.6 | 1.2% | 205,579 | Added+40,740 | |
| Harmony Biosciences Holdings inHRMY | COM | 413197104 | 7.3 | 1.2% | 201,036 | Added+81,696 | |
| Krystal Biotech IncKRYS | COM | 501147102 | 7.3 | 1.2% | 19,668 | Unchanged | |
| Annexon IncANNX | COM | 03589W102 | 7.1 | 1.1% | 1,242,455 | Reduced−50,000 | |
| Celcuity IncCELC | COM | 15102K100 | 6.7 | 1.1% | 64,110 | New+64,110 | |
| Warner Bros Discovery Inc | COM SER A | 934423104 | 6.7 | 1.0% | 250,000 | Reduced−673,725 | |
| Nektar TherapeuticsNKTR | COM NEW | 640268306 | 6.1 | 1.0% | 86,996 | Reduced−16,041 | |
| Amylyx Pharmaceuticals IncAMLX | COM | 03237H101 | 5.4 | 0.8% | 297,926 | Reduced−19,951 | |
| Acadia Pharmaceuticals IncACAD | COM | 004225108 | 4.2 | 0.7% | 167,875 | Added+23,255 | |
| Ultragenyx Pharmaceutical inRARE | COM | 90400D108 | 3.3 | 0.5% | 100,000 | Call | New+100,000 |
| Silence Therapeutics plcSLN | ADS | 82686Q101 | 3.3 | 0.5% | 300,000 | Call | New+300,000 |
| CUE Biopharma IncCUE | COM | 22978P205 | 3.0 | 0.5% | 93,819 | New+93,819 | |
| Snowflake IncSNOW | COM SHS | 833445109 | 2.5 | 0.4% | 10,000 | Unchanged | |
| Karyopharm Therapeutics IncKPTI | COM NEW | 48576U205 | 2.4 | 0.4% | 250,300 | Call | Added+200,300 |
| Aclaris Therapeutics IncACRS | COM | 00461U105 | 2.1 | 0.3% | 400,000 | New+400,000 | |
| Agios Pharmaceuticals IncAGIO | COM | 00847X104 | 1.9 | 0.3% | 50,000 | Call | New+50,000 |
| Tectonic Therapeutic IncTECX | COM | 878972108 | 1.6 | 0.3% | 46,516 | Added+8,928 | |
| Monte Rosa Therapeutics IncGLUE | COM | 61225M102 | 1.4 | 0.2% | 56,052 | New+56,052 | |
| Tenax Therapeutics IncTENX | COM NEW | 88032L605 | 1.1 | 0.2% | 75,100 | Call | New+75,100 |
| Amylyx Pharmaceuticals IncAMLX | COM | 03237H101 | 0.2 | <0.1% | 8,500 | Call | New+8,500 |
Sold out: 7 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Aardvark Therapeutics IncAARD | COM | 002942100 | 0.0 | 0.0% | 0 | Sold out−316,621 | |
| Axsome Therapeutics Inc.AXSM | COM | 05464T104 | 0.0 | 0.0% | 0 | Sold out−20,059 | |
| Karyopharm Therapeutics IncKPTI | COM NEW | 48576U205 | 0.0 | 0.0% | 0 | Sold out−52,984 | |
| Maplight Therapeutics IncMPLT | COM | 56565P103 | 0.0 | 0.0% | 0 | Sold out−112,115 | |
| Praxis Precision Medicines IPRAX | COM NEW | 74006W207 | 0.0 | 0.0% | 0 | Sold out−15,952 | |
| Soleno Therapeutics Inc | COM | 834203309 | 0.0 | 0.0% | 0 | Sold out−102,125 | |
| Ultragenyx Pharmaceutical inRARE | COM | 90400D108 | 0.0 | 0.0% | 0 | Sold out−39,473 |
Source: SEC EDGAR, Form 13F-HR, accession 0000919574-26-005024 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.